EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD)



Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD)



Neurobiology of Disease 23(2): 273-280



The twitcher mouse is a pathologically and enzymatically authentic model of globoid cell leukodystrophy (GLD, Krabbe disease) that has been widely used for the evaluation of potential therapeutic approaches. This naturally occurring mouse model contains a premature stop codon (W339X) in the galactosyleeramidase (GALC) gene that abolishes enzymatic activity. Using either immunocytochemical approaches or Western blot methodology, we have been unable to detect the truncated form of GALC expected to be produced in these animals. Nonsense-mediated mRNA decay (NMD) is a cellular protection mechanism that degrades newly synthesized transcripts containing a premature termination codon (PTC). Since the naturally occurring mutation in the twitcher mouse introduces a PTC, we hypothesized that NMD might affect the degradation of GALC mRNA in these animals. Consistent with this hypothesis, we determined that the amount of GALC transcript was inversely proportional to the number of twitcher containing alleles. Similar reductions in GALC mRNA were detected in a twitcher-derived Schwann cell line (TwS1) when compared to wild-type Schwann cells (IMS32). Anisomycin, emetine and puromycin, inhibitors of NMD, effectively increased the level of GALC transcript in the TwS1 cells providing further support for nonsense-mediated mRNA decay being the mechanism by which no GALC protein is detected in these animals. Understanding the mechanistic differences between the lack of enzymatic activity in the twitcher model and that observed with the missense mutations that cause human disease yields not only novel therapeutic insights but also highlights the need for additional animal models. (c) 2006 Elsevier Inc. All rights reserved.

(PDF emailed within 0-6 h: $19.90)

Accession: 012602457

Download citation: RISBibTeXText

PMID: 16759875

DOI: 10.1016/j.nbd.2006.03.005



Related references

Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides. Proceedings of the National Academy of Sciences of the United States of America 84(12): 4259-4263, 1987

Identification of the mutations in the GALC gene causing globoid cell leukodystrophy in Cairn and Westhighland Terriers and the twitcher mouse. Journal of Neurochemistry 66(SUPPL 1): S35, 1996

Galactosylceramidase deficiency causes sperm abnormalities in the mouse model of globoid cell leukodystrophy. Experimental Cell Research 304(1): 59-68, 2005

The twitcher mouse A model of human globoid cell leukodystrophy. Martenson, R E Myelin: Biology and chemistry ix+958p CRC Press, Inc : Boca Raton, Florida, USA; London, England, UK Illus ISBN 0-8493-8849-X : 745-759, 1992

The twitcher mouse. A model of human globoid cell leukodystrophy (krabbe's disease). American Journal of Pathology 111(3): 394-397, 1983

Metabolism of galactosylceramide in the twitcher mouse an animal model of human globoid cell leukodystrophy. Biochimica et Biophysica Acta 879(2): 215-220, 1986

The origin of renal galactosylceramide in the twitcher mouse, an animal model of human globoid cell leukodystrophy. Fukuoka Igaku Zasshi 79(7): 529-536, 1988

The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease). Brain Research 202(2): 479-483, 1980

Globoid cell leukodystrophy: specialized contact of globoid cell with astrocyte in the brain of twitcher mouse. Acta Neuropathologica 58(4): 237-242, 1982

Hematopoietic cell transplantation hct in murine globoid cell leukodystrophy gcl the twitcher mouse a model of human sphingolipid storage krabbe disease. Experimental Hematology (Charlottesville) 15(5): 449, 1987

Genetic background markedly influences vulnerability of the hippocampal neuronal organization in the "twitcher" mouse model of globoid cell leukodystrophy. Journal of Neuroscience Research 77(4): 507-516, 2004

Severe graft versus host disease in a patient with globoid cell leukodystrophy following umbilical cord blood transplantation: resemblance to the twitcher mouse model. Turkish Journal of Pediatrics 49(3): 304-306, 2007

An accumulation of galactocerebroside in kidney from mouse globoid cell leukodystrophy (twitcher). Biochemical and Biophysical Research Communications 109(3): 634-638, 1982

Fingerprint inclusions in kidney of mouse globoid cell leukodystrophy twitcher mouse. Jikeikai Medical Journal 31(2): 199-202, 1984

Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach. Cellular and Molecular Biology 49(5): 779-787, 2003